BioLife Solutions (BLFS) Misses Q2 EPS by 30c ; Offers Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $25.60 +3.27%
EPS Growth %: +109.1%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +109.1%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.33), $0.30 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $25.42 million versus the consensus estimate of $23.71 million.
GUIDANCE:
BioLife Solutions sees FY2025 revenue of $100-103 million, versus the consensus of $97.76 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- TD Cowen is selecting this stock as its "2026 Best Smidcap Idea" after pullback
- Dr. Christina Rahm and DRC Ventures Accept Prestigious Gold Stevie(R) Award for Patent-Driven Manufacturing Innovation
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
